Teva Pharmaceutical Industries Ltd. (TEVA) To Acquire Barr Pharmaceuticals Inc. (BRL)
In breaking news, two major pharmaceutical companies - Teva Pharmaceutical Industries and Barr Pharmaceuticals - announced that they have signed a definitive agreement under which Teva will acquire Barr for a total of $7.46 billion. In addition to the purchase of all shares of Barr stock at the price of $66.50 each, Teva will also assume $1.5 billion in net debt from Barr. Under the terms of the agreement, each share of Barr common stock will be converted into $39.90 in cash and 0.6272 Teva ADRs and is expected to close in late 2008. The combined company will be the…